SBIR/STTR Research Award
Liquid-Fueled Catalytic Heater for Infusion Fluids
Award amount
$70,000Program and phase
SBIR · Phase IAward year
2006Award details
- Awarding agency
- Department of Defense
- Branch
- Army
- Recipient company
- CUBE Technology
- Proposal award date
- 2006-11-09
- Contract end date
- 2007-05-06
- UEI
- SN8SCF3A1477
- Solicitation number
- 2006.2
- Topic code
- A06-157
Research abstract
CUBE Technology has created an extremely compact and efficient catalytic combustor dubbed a Nano-Furnace. These Nano-Furnaces have demonstrated an unprecedented operating range and have operated on fuels from hydrogen to butane to JP-8. This catalytic combustor will be the core of the infusion fluid warmer. This combustor is fast-starting and delivers its heat gently, via radiation and convection. The heat will be used to heat a metal susceptor with both an infusion fluid heat transfer system and an air cooling system to control the temperature rise of the infusion fluids. In addition, this system could incorporate a small power converter between the Nano-Furnace and the susceptor to make it self-powered after a short start-up time and even re-charge the start-up battery during operation.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Protective Suit Environmental Control System for CBRN, Hazardous and Emergency Responder Applications (PSECS)
- Integrated Power-Microclimate Cooling System for the Soldier
- Protective Suit Environmental Control System for CBRN, Hazardous and Emergency Responder Applications (PSECS)
- High Density or Multi-Functional Compact Power Source
- High Temperature Heat Pipes and Passive Two-Phase Cooling Systems
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
12 SBIR/STTR records share this UEI (2006–2012). Reported award amounts total $4,489,995. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Defense, Department of Health and Human Services